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Cellular/Molecular
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Presenilin (PSEN) 1 and 2 are the catalytic components of the -secretase complex, which cleaves a variety of proteins, including the
amyloid precursor protein (APP). Proteolysis of APP leads to the formation of the APP intracellular domain (AICD) and amyloid that
is crucially involved in the pathogenesis of Alzheimer’s disease. Prolyl-4-hydroxylase-domain (PHD) proteins regulate the hypoxia-
inducible factors (HIFs), themaster regulators of the hypoxic response.We previously identified the FK506 binding protein 38 (FKBP38)
as a negative regulator of PHD2. Genetic ablation of PSEN1/2 has been shown to increase FKBP38 protein levels. Therefore, we investi-
gated the role of PSEN1/2 in the oxygen sensing pathway using a variety of genetically modified cell andmouse lines. Increased FKBP38
protein levels and decreased PHD2 protein levels were found in PSEN1/2-deficient mouse embryonic fibroblasts and in the cortex of
forebrain-specific PSEN1/2 conditional double knock-outmice. Hypoxic HIF-1 protein accumulation and transcriptional activity were
decreased,despite reducedPHD2protein levels.Proteolytic-secretase functionofPSEN1/2wasneededforproperHIFactivation. Intriguingly,
PSEN1/2mutationsidentifiedinAlzheimerpatientsdifferentiallyaffectedthehypoxicresponse, involvingthegenerationofAICD.Together,our
results suggest a direct role for PSEN in the regulation of the oxygen sensing pathway via theAPP/AICD cleavage cascade.
Introduction
Hypoxia is a characteristic feature of many neurodegenerative
disorders, such as familial Alzheimer’s disease (FAD) or Parkin-
son’s disease (PD) (reviewed byOgunshola andAntoniou, 2009).
The central regulators of the response to low oxygen partial pres-
sures are the hypoxia-inducible factors (HIFs) (Wenger et al.,
2005; Semenza, 2007). Under normoxic conditions, a family of
prolyl-4-hydroxylase domain (PHD) proteins hydroxylate the
HIF subunits, tagging them for ubiquitin-mediated protea-
somal degradation (Maxwell et al., 1999; Bruick and McKnight,
2001). In hypoxia, the activity of PHDs decreases, resulting in the
stabilization and accumulation of HIF subunits that translocate
to the nucleus and heterodimerize with their constitutive coun-
terpart HIF-1/aryl hydrocarbon receptor nuclear translocator
(ARNT) (Schofield and Ratcliffe, 2004; Kaelin and Ratcliffe,
2008). The now active HIF complexes regulate genes that are
involved in hypoxic adaptation, including glucose metabolism,
angiogenesis, and neurodegeneration. The transcriptional activ-
ity of HIF is further regulated by factor inhibiting HIF (FIH) that
hydroxylates a distinct asparagine residue in the carboxy-
terminal region of HIF-, attenuating HIF transcriptional activ-
ity (Mahon et al., 2001; Lando et al., 2002).
Recently, we reported that the peptidyl-prolyl cis/trans
isomerase FKBP38 specifically interacts with PHD2 and nega-
tively regulates its stability (Barth et al., 2007; Barth et al., 2009).
FKBP38 has been shown previously to interact with presenilin
(PSEN) 1 and 2 which antagonizes its antiapoptotic function
(Wang et al., 2005). PSEN 1 and 2 form the catalytic core of the
-secretase complex (De Strooper et al., 1998;Wolfe et al., 1999).
This complex cleaves many type I membrane proteins, such as
amyloid precursor protein (APP) (De Strooper et al., 1998) or
Notch (De Strooper et al., 1999). PSEN1 and PSEN2 have been
discovered through their genetic linkage to FAD (Sherrington et
al., 1995). Despite thorough research, the underlying pathologic
processes causing AD remain elusive. However, tissue hypoxia
and hypoperfusion have been linked to the pathological progres-
sion of FAD (Ogunshola and Antoniou, 2009; Zhang and Le,
2010). Vascular ischemia/hypoxia increase APP expression and
the production of A (Kalaria et al., 1993;Webster et al., 2002; Li
et al., 2009) as well as the amyloidogenic-secretase BACE1 (Sun
et al., 2006; Zhang et al., 2007), suggesting that oxygen signaling is
also involved in the progression of AD.
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The finding that PSEN1/2-deficient mouse embryonic fibro-
blasts (MEFs) have higher FKBP38 protein levels (Wang et al.,
2005) led us to hypothesize that presenilins could be involved in
the regulation of the oxygen signaling pathway. To explore a
putative role of PSEN1/2 in PHD/HIF regulation, we analyzed
wild-type (wt), PSEN1, and PSEN2 single knock-out (ko) as well
as PSEN1/2 double-ko MEFs (Herreman et al., 1999; 2003). We
confirmed that MEF cells lacking PSEN1/2 have increased con-
stitutive FKBP38 protein levels causing decreased PHD2 protein
levels. In addition, we found that the lack of PSEN1/2 leads to an
attenuated hypoxic response that in turn results in a decreased
feedback regulation of PHD2 transcript levels. The observed ef-
fects were dependent on the generation of the APP intracellular
domain (AICD) but not on the Notch cleavage cascade.
Materials andMethods
Plasmid generation and lentiviral transduction. psG5-mPSEN1 and
pcDNA3.1-mPSEN2 expression plasmids were kind gifts of B. de
Strooper (Leuven, Belgium). The pUKBK-citAICD expression vector
was described previously (Goodger et al., 2009). PSEN and citAICD En-
try vectors were generated by cloning PCR fragments into the NcoI/XhoI
(for mPSEN1) or EcoRI/XhoI (for mPSEN2) sites of pENTR4 (Invitro-
gen). Cloning of pLenti-mPSEN and G4-DBD-PSEN1 constructs was
performed using Gateway technology (Invitrogen). The inserts of the
Entry vectors were verified by sequencing (Microsynth). Viral particles
were produced in HEK293T human embryonic kidney cells using the
ViraPower lentiviral expression system according to the manufacturer’s
protocol (Invitrogen).
Cell culture and transient transfections. PSEN wt, PSEN1 ko, and
PSEN1/2 ko, as well as MEFs containing wt human PSEN1 or clinically
relevant mutations of PSEN1 (E9, A246E, L166P) or PSEN2 (N141I),
were kindly provided by de Strooper (Herreman et al., 1999; 2003; Ben-
tahir et al., 2006). TheHeLa cervix carcinoma cell lineHeLa/trTAA/TRE-
N1-ICD, capable of doxycycline-induced expression of human
Notch1-IC (Lee et al., 2009), was a kind gift from C. O. Joe (South
Korea). APP koMEFs and APP/APPLP2 koMEFs were derived from the
corresponding ko mice (Zheng et al., 1995; von Koch et al., 1997). All
cells were grown in high-glucose DMEM (Sigma), and Notch1-IC ex-
pression was induced by 1 g/ml doxycycline (Sigma). The HEK293-
citAICD cells were described previously (von Rotz et al., 2004).
Expression of citAICDwas induced with 1M tebufenozide for 24 h. For
hypoxic exposure, cells were grown in a gas-controlled glove box (In-
vivO2 400, Ruskinn Technologies). Transient transfections ofMEFswere
performed using Lipofectamine2000 (Invitrogen). HeLa cells were tran-
siently transfected using the polyethylenimine (Polysciences) method as
described previously (Stiehl et al., 2006). The specific -secretase inhib-
itor N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl
ester (DAPT) was purchased from Sigma.
Immunoblotting. Immunoblotting was performed as described previ-
ously (Martin et al., 2005). Primary antibodies used were rabbit anti-
APP, C-terminal (Sigma A8717), rabbit anti-human PHD2 (Novus
Biologicals), rabbit anti-mouse PHD2 (Novus Biologicals), rabbit anti-
FKBP38 (Edlich et al., 2005), rabbit anti-HIF-1 (Novus Biologicals),
mouse anti-N-cadherin (BD Biosciences), mouse anti--actin (Sigma).
Horseradish peroxidase-coupled secondary anti-mouse and anti-rabbit
antibodies were purchased from Pierce. Chemiluminescence detection
was performed using Supersignal West Dura (Pierce), and signals were
recorded with a charge-coupled device camera (Lightimager LAS-
4000mini, Fujifilm).
Reporter genes and mammalian two hybrid assays. Cloning of the HIF-
dependent firefly luciferase reporter gene pH3SVL and the 885 bpmouse
Hif1a promoter constructs were described previously (Wenger et al.,
1997; 1998; Wanner et al., 2000). Cells were cotransfected with 1 g of
pH3SVL and 20 ng of pRLSV40 Renilla luciferase reporter vector (Pro-
mega). Cells were harvested in passive lysis buffer (Promega), and lu-
ciferase reporter gene activity was determined using the dual-luciferase
reporter system according to themanufacturer’s instructions (Promega).
Mammalian two-hybrid analysis was performed using the mammalian
Matchmaker system (Clontech, BD Biosciences) as previously described
(Barth et al., 2007).
Animal experimentation. Male C57BL/6 mice were maintained at the
animal facility of the University of Heidelberg, Heidelberg, Germany.
All animal procedures were approved by the animal welfare committee
(Regierungspra¨sidium Karlsruhe, Karlsruhe, Germany). Hypoxia was
induced in adult mice by substituting nitrogen for oxygen using a Diga-
mix 5SA18/3Apump (Woesthoff).Mice breathed 8%O2 for 2 to 108 hor
were kept at room air. After hypoxic exposure, organs were removed and
snap frozen in liquid nitrogen. The generation of fPSEN1/fPSEN1;
CaMKII-Cre;PSEN2ko mice was described previously (Saura et al.,
2004).
RNA extraction and quantification. Total RNA from cells or from the
cortex of fPSEN1/fPSEN1;CaMKII-Cre;PSEN2ko mice was extracted
as described previously (Wollenick et al., 2011). First-strand cDNA syn-
thesis was performed with 1.5 g RNA using affinity script reverse tran-
scriptase (RT) enzyme (Stratagene). mRNA expression levels were
quantified by real-time quantitative PCR using a SYBR Green quantita-
tive PCR reagent kit (Sigma) and a MX3000P cycler (Stratagene). Initial
template concentrations of each sample were calculated by comparison
with serial dilutions of a calibrated standard. To control for equal input
levels, ribosomal protein S12 or L28 mRNA was determined and data
were expressed as relative ratios.
Data analysis. Unless otherwise indicated, results are shown as mean
values SEM of at least three independent experiments. Statistical anal-
ysis was performed applying two-tailed or paired Student’s t test using
GraphPad Prism Version 4.0 (GraphPad Software).
Results
PSEN 1 and 2 regulate constitutive FKBP38 and PHD2 levels
and are ubiquitously expressed
To explore the function of PSEN1/2 in the hypoxia signaling
pathway, PSEN1 and PSEN2 single as well as PSEN1/2 double ko
MEFs (MEF PSEN1 ko, andMEF PSEN1/2 ko, respectively) were
used (Herreman et al., 1999; 2003). As determined by immuno-
blotting, constitutive FKBP38 protein levels were increased,
whereas PHD2 protein levels were strongly downregulated in
PSEN1/2 ko MEFs (Fig. 1A, left). Quantification of relative band
intensities of three independent experiments revealed 1.7-fold
FKBP38 upregulation and fivefold PHD2 downregulation (Fig.
1A, right). This finding is consistent with a previous report that
the lack of PSEN1/2 leads to increased FKBP38 protein abun-
dance as well as with our published results on the negative regu-
lation of PHD2 protein stability by FKBP38 (Wang et al., 2005;
Barth et al., 2007).
Because FKBP38 was clearly less increased than PHD2 was
decreased in PSEN1/2 ko MEFs, it is likely that at least one addi-
tional mechanism is involved in the regulation of PHD2 in cells
lacking PSEN1/2. Quantitative RT-PCR analysis demonstrated
that PHD2mRNA levels were also significantly lower in PSEN1/2
ko MEFs, whereas there was no difference in FKBP38 mRNA
levels (Fig. 1B). We further analyzed hypoxic PHD2 protein in-
duction in PSEN1/2 wt and ko MEFs. Both normoxic and hy-
poxic PHD2protein levels were substantially lower in the absence
of PSEN1/2 at each time point tested (Fig. 1C). FKBP38 protein
levels did not change in hypoxia, as reported previously (Barth et
al., 2007). Relative hypoxic PHD2 induction, however, remained
unchanged compared with normoxic PHD2 protein levels in
each cell line (Fig. 1D).
In vivo, we found ubiquitous PSEN1/2 expression in adult
mouse tissues with most abundant PSEN1 mRNA levels in the
testis and the brain, and with high PSEN2 mRNA levels in the
liver and the brain (Fig. 1E). Although exposure to inspiratory
hypoxia (8% O2) for 12 or 108 h induced mRNA levels of the
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HIF-target gene EPO in the brain by 25-fold and 26-fold, respec-
tively, and in the kidney by 168-fold and 53-fold, respectively
(data not shown), no hypoxic induction of PSEN1 or PSEN2
itself could be detected, either in these mouse tissues (Fig. 1E) or
in various human cell lines (data not shown).
PSEN-deficient cells show an attenuated hypoxic response
To investigate whether the constitutive decrease in PHD2 levels
in PSEN1/2-deficient cells affects the hypoxic response function-
ally, wt, single ko, double ko, and lentivirally reconstitutedMEFs
were transiently cotransfected with a hypoxia response element-
driven firefly luciferase reporter gene together with a constitutive
Renilla luciferase control vector. After transfection, cells were
split and exposed to normoxia or hypoxia for 16 h.Unexpectedly,
despite decreased PHD2 levels, both hypoxicHIF-1 protein lev-
els and HIF-dependent reporter gene expression were decreased
in PSEN1/2 koMEFs (Fig. 2A). Reconstitution by lentiviral reex-
pression of wt PSEN1 (C1) or PSEN2 (C2) almost completely
rescued the hypoxic HIF-1 protein levels and reporter gene in-
duction, excluding clonal artifacts and demonstrating that both
PSEN1 andPSEN2 are independently involved inHIF regulation.
Hypoxic induction of mRNA levels derived from the well-
established HIF-target genes carbonic anhydrase (CAIX), PHD2,
N-myc downstream-regulated gene (NDRG1) and BCL2/adeno-
virus E1B interacting protein (BNIP3) was blunted in PSEN1/2
ko MEFs (Fig. 2B), confirming a functional decrease of endoge-
nous HIF activity in the absence of PSEN1/2. Physiological oxy-
gen partial pressures in the brain are in the range of 25–35mmHg
(Baker, 1975), which corresponds to a gas phase oxygen concen-
tration of 3–5%. However, cultured cell lines adapted to 20% O2
and exposed to 5%O2 or lower will still react to this acute relative
decrease in oxygen supply by an HIF- induction (Stiehl et al.,
2006). To confirm our findings in less severe hypoxia, PSEN1/2
wt and ko MEFs were cultured in 20%, 5%, or 0.2% O2 condi-
tions for 16 h before HIF-1 and PHD2 protein levels were ana-
lyzed by immunoblotting. Hypoxic HIF-1 induction was
blunted in PSEN1/2 ko MEFs, independent of the severity of
relative hypoxia (Fig. 2C). Of note, hypoxic induction of the
HIF-1 target gene PHD2 efficientlyworked only at 0.2%, an effect
that can be explained by fine-tuning HIF-1 transcriptional ac-
tivity by FIH-mediated asparagine hydroxylation. Because FIH
has a higher O2 affinity than the PHDs, HIF target genes, such as
PHD2, are at best modestly increased after exposure to 5% O2.
PSEN1 is required for normalHif1a gene expression
To further analyze the PSEN1/2-dependent regulation of the
hypoxiapathway,HIF-1protein stabilitywasexamined.Because in
normoxia HIF-1 is virtually undetectable because of rapid
hydroxylation-dependent proteasomal degradation, HIF-1 pro-
teindecaywas estimatedunderhypoxic conditions only. After 16 h
of hypoxia, the translation inhibitor cycloheximide was added to
PSEN1/2 wt and ko MEFs. HIF-1 protein levels were analyzed
by immunoblotting after 0, 0.5, 1, 2, and 4 h of ongoing hypoxia
and cycloheximide treatment (Fig. 3A). Quantification of the
Figure1. Regulation of FKBP38andPHD2byPSEN1andPSEN2 innormoxia andhypoxia.A, Total cell extracts fromPSEN1/2wt and koMEFswere analyzed for PHD2, FKBP38, and-actin protein
levels by immunoblotting (left). Relativeband intensities of three independent experimentswerequantifiedbydensitometry (right). Data are shownasmeanSDvalues. *p0.05 (t test). **p
0.005 (t test).B, Total RNAwasextracted fromPSEN1/2wtandkoMEFs. Transcript levels of FKBP38andPHD2werequantifiedbyquantitativeRT-PCRandnormalized to ribosomal protein S12mRNA
levels. *p 0.05 (t test). n.s., Not significant. C, PSEN1/2 wt and ko MEFs were cultured in normoxia or hypoxia for the time indicated, and PHD2 and FKBP38 protein levels were analyzed by
immunoblotting.D, Relative band intensities of three independent experimentswere quantified by densitometry. The 0 h time point of each cell linewas defined as 1. E, Total RNAwas derived from
organs of mice that were kept at 20% or 8% oxygen for the time indicated. PSEN1 and PSEN2 transcript levels were quantified by quantitative RT-PCR and normalized to the ribosomal protein S12
mRNA levels. Data are shown as mean SEM values of three independent RNA extractions from different mice.
Kaufmann et al. • Presenilins Regulate PHD/HIF Signaling J. Neurosci., January 30, 2013 • 33(5):1915–1926 • 1917
protein degradation rate of three independent experiments re-
vealed that the hypoxic half-life of HIF-1 protein was 2.5 h
and did not differ between the two cell lines (Fig. 3B).
Because HIF-1 protein stability was not altered in PSEN1/2
ko MEFs, HIF-1mRNA levels were determined by quantitative
RT-PCR. Transcript levels in PSEN1/2 ko MEFs were decreased
by almost 50% compared with the wt control (Fig. 3C). To deter-
mine HIF-1mRNA stability in PSEN1/2 wt and ko MEFs, cells
were treated with actinomycin D for up to 24 h and transcript
levels quantified by quantitative RT-PCR. Neither HIF-1,
PHD2, nor VEGFA mRNA stability was found to be altered in
PSEN1/2 ko MEFs (Fig. 3D), suggesting that HIF-1 mRNA is
transcriptionally regulated and not via degradation.
BecauseHif1a promoter activity likely is responsible for the
difference in HIF-1mRNA levels, a previously published 885
bp fragment upstream of the transcriptional start site of the
mouseHif1a gene, cloned into a promoterless firefly luciferase
reporter gene vector (Wenger et al., 1998), was used to deter-
mine HIF-1 transcription rates. A cotransfected pSV40-
Renilla vector served as an internal control to correct for
differences in transfection efficiency and extract preparation.
Luciferase expression was determined 48 h after transfection,
and values were normalized to the activity of the promoterless
vector pGL3basic in wt MEFs. As shown in Figure 3E, Hif1a
promoter activity was significantly lower in PSEN1/2 ko than
in wt MEFs. Hif1a promoter activity was rescued to almost wt
levels in two different clones of ko MEFs that were lentivirally
reconstituted with PSEN1/2.
-Secretase enzymatic activity is required for PSEN-
dependent regulation of HIF-1 but not of FKBP38/PHD2
Most of the known functions of PSEN1/2 require -secretase
proteolytic activity (Wakabayashi and De Strooper, 2008). To
determine whether -secretase activity is also required for the
regulation of the hypoxia pathway, PSEN1/2 wt and ko MEFs
were cultured under normoxic or hypoxic conditions for 12 h in
the presence of either DMSO alone (control) or 2 or 4MDAPT,
a specific -secretase inhibitor. As shown in Figure 4A, inhibition
of -secretase activity reduced HIF-1 protein levels but did not
have any effect on FKBP38 or PHD2 protein levels. The accumu-
lation of the C-terminal fragment ofN-cadherin served as a con-
trol for DAPT function. This finding further supports that the
regulation of the hypoxia pathway takes place on more than
one level, comprising -secretase-dependent and -secretase-
independent mechanisms. To confirm our results in neuronal
cells, SH-SY5Y neuroblastoma cells were treated with either
DMSO alone (control) or with 2 or 4 M DAPT before exposure
to 20% or 0.2% O2 for 16 h. -Secretase inhibition using 4 M
DAPT reduced hypoxicHIF-1 protein levels by 24%but did not
affect PHD2 protein levels in SH-SY5Y cells (Fig. 4B).
Notch is one of the many -secretase substrates and has been
described to potentiate the hypoxic response in certain cell lines
on various levels, involving the direct interaction of HIF-1with
Notch intracellular domain (NICD) and the recruitment of
HIF-1 to NICD responsive promoters (Gustafsson et al., 2005).
To analyze whether PSENs act on the hypoxia pathway via Notch
signaling, HeLa/trTAA/TRE-N1-IC cells were used, allowing in-
Figure 2. HIF transcriptional response to hypoxia in PSEN1/2-deficient cells.A, wt, PSEN1/2 ko (ko), PSEN1 ko (1ko), and two reconstituted clones of PSEN1/2 ko (C1 or C2)MEFswere transiently
transfected with the HIF-dependent reporter pH3SVL and pRL-SV40 constructs and cultured in 20% or 0.2% O2 for 16 h before relative luciferase activities were determined. The results are shown
as mean SEM values of three independent experiments performed in triplicates (top). HIF-1 and-actin protein levels were determined by immunoblotting (bottom). B, PSEN1/2 wt and ko
MEFswere cultured in 20%or 0.2%O2 for 4, 8, 16, and 32h and total RNAwas extracted. CAIX, PHD2, NDRG1, andBNIP3 transcript levelswere quantified by RT-PCR andnormalized to the expression
of ribosomal protein S12mRNA. Data are shownasmean SEMvalues of five independent experiments. Student’s t testswere used to statistically evaluate the reduction (if any) of theseHIF target
genes by PSEN1/2 deficiency at each time point. *p 0.05. **p 0.01. C, PSEN1/2wt and koMEFswere cultured in 20%, 5%, or 0.2%O2 for 16 h before HIF-1, PHD2, and-actin protein levels
were analyzed by immunoblotting.
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duced expression of the humanNotch1-IC by doxycycline (Lee et
al., 2009). Protein levels of doxycycline or vehicle-treated HeLa
cells were analyzed after 16 h exposure to 20% or 0.2% O2. As
shown in Figure 4C, hypoxic accumulation of HIF-1 and PHD2
werenotaffectedbyNICDinduction.Consistently, althoughPHD2,
CAIX, andGLUT1mRNA levels were induced 2.5- to 100-fold after
16 h of hypoxic exposure, they remained unchanged by NICD in-
duction (Fig. 4D). Increased SNAIL mRNA levels confirmed the
activation of the Notch pathway (Fig. 4D). These findings suggest
that PSEN-dependentHIF regulation in ourmodels is not the result
of alterations in the Notch signaling pathway.
Gain-of-function as well as (partial) loss-of-function mutations
in PSEN1/2 are strongly associated with FAD. Therefore, we sought
toanalyze theeffectsof several clinically relevantPSENmutationson
thehypoxiapathwaybyusingPSEN1/2wtandkoMEFs,orkoMEFs
stably reconstitutedwithhumanPSENmutants commonly found in
FADpatients (PSEN1-E9, PSEN1-A246E, PSEN1-L166P, PSEN1-
G384A, and PSEN2-NI41I) (Bentahir et al., 2006). These cells were
transiently transfected with the HIF-dependent reporter gene
pH3SVL and luciferase activity wasmeasured after 16 h of exposure
to either 20% or 0.2% O2. Whereas reintroduction of PSEN1-
A246E, PSEN1-G384A, andPSEN2-N141I partially rescuedHIF ac-
tivity inhypoxicPSEN1/2koMEFs, PSEN1-E9andPSEN1-L166P
failed todo so (Fig. 4E).Ofnote,whereas the former threemutations
are still able to cleave some substrates (e.g., APP)butnot others (e.g.,
Notch), -secretase function of the latter two mutations has been
showntobe severely impairedandtoabolishcanonicalAPPcleavage
as well asNICD formation (Bentahir et al., 2006; Shen andKelleher,
2007), confirming the results obtained with the DAPT -secretase
inhibitor.
RegulationofHIF-1proteinandmRNAlevelsvia APP/AICD
The finding that MEFs bearing PSEN mutations that are unable to
generate theNICDbut still cleave theAPPshowafunctionalhypoxic
response led us to hypothesize that AICD might be crucial for HIF
regulation. Therefore, HIF-1 protein levels were determined in
HEK293-citAICD, a human embryonic kidney cell line that al-
lows for tebufenozide induction of AICD expression (von Rotz
Figure3. HIF-1 regulation in PSEN1/2-deficient cells.A, PSEN1/2wt andkoMEFswere cultured in 20%or 0.2%O2 for 16hbefore treatmentwith 100M cycloheximide. Total cell extractswere
prepared after 0.5, 1, 2, and 4 h of treatment. HIF-1, and-actin protein levels were analyzed by immunoblotting.B, Relative band intensities of three independent experiments were quantified
relative to the-actin levels and normalized to the 0 h hypoxia time points. Mean values SEM of three independent experiments are shown. C, Quantification of HIF-1mRNA levels in PSEN1/2
wt and koMEFs by quantitative RT-PCR. Transcript levelswere normalized to themRNA levels of ribosomal protein S12, and thewt levelwas defined as 1.D, PSEN1/2wt and koMEFswere incubated
at 0.2%O2 for 16hbefore5g/ml actinomycinDwasadded to the cells. Total RNAwasextractedafter 0, 4, 8, 16, and24hof actinomycinD treatment, andHIF-1, PHD2, andVEGFA transcript levels
werequantifiedbyRT-PCR.mRNA levelswerenormalized to ribosomal protein S12mRNA, and the0h timepointwasdefinedas 1. The results are shownasmeanSEMvalues of three independent
experiments. E, PSEN1/2 wt, ko, and two PSEN1/2 reconstituted clones were transiently cotransfected with the Hif1a promoter-driven pGL3–885Hif1a or the promoterless pGL3-basic plasmid
togetherwith thepSV40-RL control vector. Datawerenormalized to theRenilla luciferase activities and are shownasmean SEMvalues of three independent experiments performed in triplicates.
*p 0.05,(t test). n.s., Not significant (t test).
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et al., 2004). After tebufenozide treat-
ment, HIF-1 but not PHD2 protein lev-
els were increased (Fig. 5A, left). Because
normoxic HIF-1 protein is rapidly de-
graded and therefore not detectable,
HIF-1 protein levels were analyzed in
HEK-cit AICD grown in 20% O2 using
prolonged exposure times. As shown in
Figure 5A, right panel, also normoxic
HIF-1 protein levels were induced after
AICD overexpression. On the mRNA
level, HIF-1 and its target genes PHD2
and CAIX were increased after AICD
overexpression under normoxic condi-
tions as well as after 4–24 h of hypoxic
exposure (Fig. 5B). The overall oxygen-
independent HIF-1, PHD2, and CAIX
mRNA levels increased significantly by 40, 19,
and 95%, respectively (p 0.05, paired Stu-
dent’s t test). AICD overexpression was veri-
fied by immunoblotting (Fig. 5A) as well as
quantitativeRT-PCR (Fig. 5B).
To further explore the involvement of
APP/AICD in the hypoxic response, we
analyzedHIF-1 and PHD2protein levels
in APP wt, APP ko, and APP/APP-like
protein 2 (APLP2) double koMEFs by im-
munoblot analysis. APLP2 has been
shown to be able to partially take over the
function of APP (Heber et al., 2000; Yang
et al., 2005). Hypoxic HIF-1 accumula-
tion was blunted in the absence of APP
alone andwas further decreased slightly in
APP/APLP2 koMEFs on both the protein
(Fig. 5C) and the mRNA levels (Fig. 5D).
Although the HIF-1 target gene PHD2
was not significantly affected, the overall
oxygen-independent CAIX mRNA levels
decreased significantly by 56% (p 0.05,
paired Student’s t test) in APP/APLP2 ko
MEFs (Fig. 5D). Finally, we investigated
whether AICD overexpression is sufficient to
rescue the blunted hypoxic response after
-secretase inhibition. Therefore, AICDover-
expression in Hek293-citAICD cells was in-
duced for 16 h before -secretase activity was
blocked by DAPT treatment for 8 h and the
cells incubated at 20% or 0.2% O2. Whereas
AICD overexpression resulted in increased
hypoxicHIF-1protein levels,-secretase in-
hibition reducedHIF-1 but not PHD2 pro-
tein levels in the presence and absence of
AICD(Fig.5E,F).Thesefindingsindicatethat
theAPP/AICDcleavage cascade is involved in
PHD/HIF signaling but is likely not the only
-secretase substrate involved in these effects.
Decreased HIF-1 expression in the
cortex of forebrain-specific PSEN1/2 conditional double
knock-out mice
To confirm the relevance of our findings in vivo, we analyzed the
cortex region of forebrain-specific fPSEN1/fPSEN1;CaMKII-
Cre;PSEN2ko PSEN1/2 conditional double knock-out (PSEN1/2
cdko) mice (Saura et al., 2004). HIF-1, HIF-2, PHD2, and
VEGFA mRNA levels were found to be significantly downregu-
lated in the cortex of these mice, whereas there was no difference
in FKBP38 and the HIF-target gene NDRG1 mRNA levels (Fig.
6A). In line with the mRNA levels, PHD2 protein levels were
Figure4. Requirement of-secretase enzymatic activity for presenilin-dependent regulation ofHIF-1, FKBP38, andPHD2.A,
PSEN1/2wt and koMEFswere pretreatedwith 0, 2, or 4M of the-secretase inhibitor DAPT before culturing at 0.2%O2 for 12 h.
HIF-1, FKBP38, PHD2, N-cadherin, and -actin protein levels were determined by immunoblotting. B, SH-SY5Y cells were
cultured at 20% or 0.2% O2 for 16 h in the presence of 0, 2, or 4M DAPT, and HIF-1, PHD2, and -actin protein levels were
analyzed by immunoblotting. C, D, HeLa/trTAA/TRE-N1-ICD cells were cultured for 24 h in the presence or absence of 1 M
doxycycline before exposure to 20%or 0.2%O2 for 16 h. Thereafter, HIF-1, PHD2, and-actin protein levelswere determined by
immunoblotting (C) and PHD2, GLUT1, CAIX, and Snail mRNA levels were quantified by quantitative RT-PCR (D). Transcript levels
were normalized to themRNA levels of ribosomal protein L28. The untreated normoxic controlwas defined as 1. Data are shownas
mean SEM values of three independent experiments. E, PSEN1/2 wt, ko, and ko MEFs stably expressing PSEN1 or PSEN2 FAD
mutations (E9, A246E, L166P, G384A, and N141I) were transiently cotransfected with the hypoxia response element-driven
luciferase reporter plasmid (pH3SVL) together with the pSV40-RL control vector. Cells were cultured for 16 h at 20% or 0.2% O2
before luciferase activity was determined. The results are shown as mean  SEM values of three independent experiments
performed in triplicates.
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Figure 5. Regulation of HIF by the APP/AICD cleavage cascade. A, Hek293-citAICD cells were pretreated with 1 M tebufenozide for 24 h before culturing at 20% or 0.2% O2 for 16 h and
determination of HIF-1, PHD2, APP, and-actin by immunoblotting (left). In a separate experiment, normoxic HIF-1was detected using a prolonged exposure time (right). B, Hek293-citAICD
cells were cultured for 24 h in the presence or absence of 1M tebufenozide and exposed to 20% or 0.2% O2 for the time indicated, before mRNA levels of HIF-1, PHD2, CAIX, and AICD were
quantified by RT-PCR. The transcript levels were normalized to ribosomal protein L28 mRNA levels, and the zero hour time point of the control cells was defined as 1. C, APP wt, APP ko, and
APP/APPLP2 koMEFswere cultured at 20%or 0.2%O2 for 16h, andHIF-1, PHD2, and-actin protein levelswere determinedby immunoblotting.D, APPwt, APP ko, andAPP/APLP2 koMEFswere
exposed to 0, 4, 8, 16, or 24 h of 0.2% O2, and mRNA levels of HIF-1, PHD2, and CAIX were quantified by RT-PCR. Transcript levels were normalized to ribosomal protein S12 mRNA levels. E, F,
Hek293-citAICDcellsweregrown in thepresenceor absenceof 1M tebufenozide for 16hbefore8hpretreatmentwithDMSOorDAPTand subsequent incubationat20%or0.2%O2 for 16h.HIF-1,
PHD2, and AICDwere determined by immunoblotting (E), andHIF-1 band intensitieswere quantified and normalized to-actin (F ). Data are shown asmean SEM values of three independent
experiments. *p 0.05 (t test).
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decreased by 65%, whereas FKBP38
protein remained unaffected in the cortex
of PSEN1/2 cdko mice (Fig. 6B,C). Fur-
thermore, we investigated BACE1 expres-
sion levels, which have been shown
previously to be induced by hypoxia in a
HIF-dependent manner (Zhang et al.,
2007). In line with this report, BACE1
mRNA levels were lower in the brain of
PSEN1/2 cdko mice (Fig. 6A).
In summary, our findings demonstrate
that PSEN1/2 are involved in the regula-
tion of the oxygen-sensing pathway in
cells of various origins in vitro as well as in
cortical neurons in vivo.
Discussion
Many neurological diseases, such as AD
and PD, are characterized by tissue hyp-
oxia, but whether hypoxia is a cause or a
consequence of the disease remains un-
clear (Peers et al., 2009). In this report, we
show that PSEN1 and PSEN2 modulate
the functional response to hypoxia on
more than one level (schematically sum-
marized in Fig. 7). MEFs lacking PSEN1/2
showed increased constitutive FKBP38
and concomitantly decreased PHD2 pro-
tein levels. These findings are in linewith a
previous report, showing that genetic ab-
lation of PSEN1/2 increases FKBP38 pro-
tein levels (Wang et al., 2005) and with
our previous results showing that FKBP38
negatively regulates PHD2 protein levels
(Barth et al., 2009). Neither PSEN1 nor
PSEN2 was regulated by hypoxia in any of
the mouse tissues or cell lines analyzed,
even though some reports showed an in-
duction of PSEN1 after hypoxic exposure of glial cells (Bazan and
Lukiw, 2002; Cui et al., 2004). However, FKBP38 protein levels
were only slightly upregulated, suggesting that additional mech-
anisms contribute to the decreased PHD2 levels. Consistently,
not only PHD2 protein but also mRNA levels were substantially
downregulated in PSEN1/2-deficient MEFs.
Because we and others previously showed that even slight
changes in PHD2 protein levels affect HIF-1 protein stability
(Stiehl et al., 2006; Ginouve`s et al., 2008; Henze et al., 2010), the
clearly reduced PHD2 levels in PSEN1/2-deficientMEFs led us to
expect that HIF-1 protein and HIF target gene expression will
be induced in these cells. However, quite surprisingly, PSEN1/2-
deficientMEFs also showed a decreasedHIF response, despite the
strongly decreased PHD2. Because PHD2 is a direct target of
HIF-1, these findings might provide the additional mechanism
involved in PHD2 downregulation, but they cannot explain the
HIF-1 downregulation. PHD3 protein levels were not affected
by the loss of PSEN1/2, whereas PHD1 expression was almost
undetectable in PSEN1/2 wt and ko MEFs (data not shown).
Interestingly, the lack of PSEN1/2 lowered both Hif1a pro-
moter activity andHIF-1mRNA levels inMEFs. In line with the
in vitro data, HIF-1, HIF-2, PHD2, and VEGFA RNA and
PHD2 protein levels were decreased in the cortex of forebrain-
specific PSEN1/2 cdko mice. These in vitro and in vivo results
confirm previous descriptive in vivo gene array data demonstrat-
ing that HIF-1mRNA levels are decreased in PSEN1 hypomor-
phic mice (Liauw et al., 2002; Rozmahel et al., 2002). However, it
is currently unclear whether the 50% decrease in HIF-1mRNA
levels alone could explain the more pronounced (80%) decrease
in hypoxic HIF-1 protein. During the progression of our study,
De Gasperi et al. (2010) showed that PSEN1 ko MEFs display
impaired induction of HIF-1 after stimulation with hypoxia
mimetics, insulin, and calciumchelators (DeGasperi et al., 2010).
These authors attributed their findings to a shorter half-life of
HIF-1 in PSEN1-deficient MEFs. However, using PSEN1/2-
deficientMEFs, we could not find any decrease inHIF-1protein
stability. Two main differences between our experiments and
those performed by De Gasperi et al. (2010) might explain this
discrepancy: (1) we conducted our analysis in double-ko MEFs;
and (2) we measured HIF-1 decay after a controlled hypoxic
accumulation because HIF-1 is normally not detectable under
normoxic conditions.
Together with PSEN enhancer (Pen-2), nicastrin, and ante-
rior pharynx 1 (Aph-1), PSENs form the core of the -secretase
complex that cleaves a variety of type I transmembrane proteins
(De Strooper et al., 1999; Parks and Curtis, 2007). Several studies
implied that PSEN also have -secretase-independent functions
(reviewed byWakabayashi and De Strooper, 2008). Accordingly,
we showed that, although the -secretase function of PSEN1/2 is
essential for hypoxic HIF-1 induction, it does not affect the
protein levels of FKBP38 and PHD2, further underlining that at
Figure 6. PSEN1/2 regulate PHD2/HIF in the brain. A, Cortical mRNA of control C57BL6/129 and PSEN1/2 cdko mice was
quantified by RT-PCR andnormalized to the transcript levels of the ribosomal protein S12.B, C, PHD2, FKBP38, and-actin protein
levelsweredeterminedby immunoblotting (B), andPHD2andFKBP38band intensitieswerequantifiedandnormalized to-actin
(C). Data are shown as mean SEM values of n 3 animals per group. *p 0.05 (t test). **p 0.01 (t test). ***p 0.001 (t
test).
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least two independent mechanisms are involved in PSEN-
dependent HIF regulation.
NICD and AICD are two major -secretase-dependent intra-
cellular cleavage products (derived from the Notch and APP pre-
cursors, respectively), and NICD has been shown previously to
potentiate the HIF response in neuronal and myogenic cells
(Gustafsson et al., 2005). However, in the cell models used in this
study, AICDbut notNICD regulatedHIF-1 andHIF target gene
expression. The function of AICD remains incompletely under-
stood, but it has been shown to be present in nuclear complexes
involved in nuclear signaling (Cao and Sudhof, 2001; von Rotz et
al., 2004). Nuclear signaling function of AICD requires its asso-
ciationwith the APP adaptor protein Fe65 and the histone acetyl-
transferase Tip60 (Cao and Sudhof, 2001). Of note, several genes
regulated by AICD have been identified, including KAI1 (Baek et
al., 2002), glycogen synthase 3 (Kim et al., 2003), APP, and
BACE (von Rotz et al., 2004). Our results suggest that HIF-1
might represent a novel AICD target gene, but further mech-
anistic experiments need to be performed to corroborate this
hypothesis. Because -secretase inhibition decreased hypoxic
HIF-1 protein accumulation, even in the
presence of overexpressed AICD, addi-
tional -secretase substrates are likely to
be involved in HIF regulation. A recent
report by LeMoan et al., 2011 showed that
-secretase activity is increased in hypoxia
by an unknownmechanism, leading to in-
creased HIF-1 stability. Even though
PSEN1/2 was not investigated, we found
that genetic ablation of the -secretase
substrate p75 neurotrophin receptor re-
duced hypoxic HIF-1 stabilization.
Their findings were explained through
decreased Siah2 abundance after p75 ab-
rogation. Siah2 has been proposed previ-
ously to negatively regulate PHD1 and
PHD3, and decreased Siah2 hence would
lead to lowered HIF-1 protein and HIF
target gene expression (Nakayama et al.,
2004). Accordingly, Le Moan et al., 2011
found decreased PHD3 mRNA levels as a
result of a bluntedHIF-response in p75 ko
MEF cells. However, in our hands, over-
expression of the full-length p75 or the
p75 intracellular domain did not affect
hypoxic HIF-1 protein levels, suggesting
that the p75/p75ICD cascade is not the
major regulator of the hypoxia pathway in
our cellular model (data not shown). To
date, it remains unclear which other
-secretase substrate(s) in addition toAPP/
AICD is/are involved in the regulation of
the HIF signaling cascade. Furthermore,
DAPT inhibits the cleavage of endoge-
nous APP. Fe65 binds APP and is thus less
available for binding the overexpressed
AICD to translocate with it into the nu-
cleus (Cao and Sudhof, 2001; Wiley et al.,
2007). This might be an additional expla-
nation for the decreased HIF-1 protein
levels after DAPT treatment in the pres-
ence of overexpressed AICD.
To investigate the role of APP and
APLP2 of the mouse brain in vivo, C57BL/6 wt, APPfl/fl/APLP2
ko (Mallm et al., 2010), and Nex-Cre/APPfl/fl/APLP2 cdko mice
were exposed to 6 h of 20% or 6%O2 and transcript levels quan-
tified.While EPO and VEGFAmRNAs were hypoxically induced
by 20-fold and 4-fold, respectively, there was no difference be-
tween the three genotypes (data not shown). APP deletion effi-
ciency in the cortex of Nex-Cre/APPfl/fl/APLP2 cdko mice was
70% on both mRNA and protein levels (data not shown). Of
note, APP expression levels are very high in the brain, and the
remaining levels of APPmight be sufficient to elicit a normal HIF
response,making the results of thesemousemodels inconclusive.
Despite several in vitro and in vivo studies showing a direct
link between A and toxicity in FAD, the molecular nature of
this interplay remains elusive (reviewed by Hardy and Selkoe,
2002). An increasing number of reports provide evidence for
nonphysiological metal accumulation in the brains of patients
with neurodegenerative diseases, such as AD or PD (Barnham
and Bush, 2008). Iron and other transition metals can interact
with A, leading to increased A deposition and to neuronal
death through oxidative damage (Smith et al., 1997). A novel
Figure 7. Scheme of the mechanisms involved in the regulation of HIF by PSENs. PSEN1/2 -secretase-mediated cleavage of
the APP generates A involved in AD aswell as the AICD that inducesHif1a gene expression and HIF-1 protein stability but does
not regulate FKBP38/PHD2. On the other hand, PSEN1/2 increases PHD2 activity by inhibiting FKBP38 in a -secretase-
independentmanner. These twomechanismsoverlapwithhypoxic inductionofHIF-1protein stability and finally converge in the
downregulation of HIF-dependent target gene expression after deletion or functional mutation of PSEN1/2.
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class of drugs target the abnormal metal accumulation,
thereby reducing A deposition and oxidative stress in the
brain (Cuajungco et al., 2000; Doraiswamy and Finefrock,
2004). Recently, M30 (5-(N-methyl-N-propargyaminomethyl)-8-
hydroxyquinoline) and HLA20 (5-[4-propargylpiperazin-1-
ylmethyl]-8-hydroxyquinoline), two novel iron chelating drugs
have been evaluated as therapeutic agents in AD (Zheng et al.,
2005). Of note, iron chelators are well known as PHD-inhibiting
and HIF-activating compounds (Wang and Semenza, 1993;
Wanner et al., 2000; Linden et al., 2003). In particular, M30 has
been shown to upregulate HIF and HIF-target genes in cortical
neurons (Avramovich-Tirosh et al., 2010). This suggests thatHIF
activation in the brain might be beneficial for patients suffering
from AD and cognitive dysfunction, and that mechanisms im-
peding HIF activation might be involved in the pathogenesis of
the disease. Indeed, the classical HIF-target genes EPO and
VEGFAhave been shown to improve cognitive function inmouse
models when activated in the brain (Plaschke et al., 2008; Sargin
et al., 2011). However, additional studies will be required to in-
vestigate whether HIF-1 can rescue age-dependent neurode-
generation in PSEN1/2 cdkomice. On the other hand, it has been
suggested that hypoperfusion/hypoxia maymediate AD progres-
sion (Ogunshola and Antoniou, 2009). Of note, a recent report
showed elevated expression of HIF-1 in the brain microvascu-
lature of an AD mouse model (Grammas et al., 2011). Further-
more, hypoxia has been shown to increase the expression of
BACE1 (Sun et al., 2006; Zhang et al., 2007) and as a consequence
the production of A (Kalaria et al., 1993;Webster et al., 2002; Li
et al., 2009). In line with these data, we found lower BACE1
expression in the brain of PSEN1/2 cdko mice. This suggests that
decreased A production after PSEN1/2 ablation might partially
be mediated by HIF and BACE1. In conclusion, HIF-1 activation
might exert temporally and spatially diverse functions during the
progression of AD.
Intriguingly, PSEN1/2-deficientMEFs thatwere reconstituted
with mutations originally identified in AD patients displayed a
differential response to hypoxia. Although the most severe
-secretase loss-of-functionmutations (E9, L166P) did not res-
cue HIF transcriptional activity, the other mutations (A246E,
G384A, N141I) showed an intermediate hypoxic response, con-
firming the importance of -secretase enzymatic activity for HIF
regulation. Extensive analysis of -secretase activity in the differ-
ent PSEN clinicalmutations revealed decreased AICD levels in all
mutations with the highest reduction in the L166 mutant
(Bentahir et al., 2006; Chavez-Gutierrez et al., 2012). Taking into
consideration that FAD is a multifactorial progressive neurode-
generative disease, these results suggest that HIF-1 protein lev-
els and HIF transcriptional activity in the brain of AD patients
deserve more clinical attention.
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